Results 151 to 160 of about 3,893,535 (160)

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up

European Journal of Cancer, 2016
Matthias Miederer, Bernd Krause, Alexander R Haug   +2 more
exaly  

Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy

Pharmaceuticals, 2019
Ute Hennrich, Klaus Kopka
exaly  

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors

Seminars in Oncology, 2018
Thorvardur R Halfdanarson, John K Ramage, Boris G Naraev   +2 more
exaly  

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs

Bailliere's Best Practice and Research in Clinical Gastroenterology, 2012
Guido Krenning, Peeters Robin, Wouter W de Herder   +2 more
exaly  

Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Thoracic Surgery Clinics, 2014
Lisa Bodei, Marta Cremonesi, Mark Kidd
exaly  

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Nuclear Medicine and Molecular Imaging, 2017
Keunyoung kim, Seong-Jang Kim
exaly  

Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours

Cancer Treatment Reviews, 2018
Javier Aller, Jaume Capdevila, Cristina Rodríguez-Antona   +2 more
exaly  

Peptide receptor radionuclide therapy

Best Practice & Research Clinical Endocrinology & Metabolism, 2007
Guido Krenning, Marion de Jong, Flavio Forrer   +2 more
exaly  

Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature

Cancer Biotherapy and Radiopharmaceuticals, 2014
Ernesto Amato, Fabio Minutoli, Alessandro Sindoni   +2 more
exaly  

Peptide Receptor Radionuclide Therapy (PRRT)

2016
Ashutosh Dash, F F Knapp
exaly